Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $19.2 Million - $23.2 Million
115,941 New
115,941 $19.6 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $5.85 Million - $7.2 Million
39,447 Added 142.46%
67,136 $9.96 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $2.11 Million - $2.71 Million
-13,532 Reduced 32.83%
27,689 $4.76 Million
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $7.29 Million - $9.41 Million
40,194 Added 3913.73%
41,221 $7.77 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $777,084 - $991,084
-4,012 Reduced 79.62%
1,027 $251,000
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $150,674 - $166,913
796 Added 18.76%
5,039 $978,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $211,887 - $235,198
1,349 Added 46.61%
4,243 $702,000
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $2.55 Million - $3.07 Million
-18,583 Reduced 86.53%
2,894 $479,000
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $2.4 Million - $3.06 Million
21,477 New
21,477 $2.94 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $1.02 Million - $1.17 Million
-8,760 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $694,782 - $792,669
6,172 Added 238.49%
8,760 $1.09 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $103,270 - $120,451
1,054 Added 68.71%
2,588 $294,000
Q1 2019

May 15, 2019

BUY
$81.56 - $100.67 $125,113 - $154,427
1,534 New
1,534 $154,000
Q1 2018

May 15, 2018

SELL
$71.51 - $84.69 $383,293 - $453,938
-5,360 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $337,195 - $388,169
5,332 Added 19042.86%
5,360 $386,000
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $1,672 - $1,831
28
28 $2,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.